Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study

Shu Nan Qi, Yong Yang, Yu Jing Zhang, Hui Qiang Huang, Ying Wang, Xia He, Li Ling Zhang, Gang Wu, Bao Lin Qu, Li Ting Qian, Xiao Rong Hou, Fu Quan Zhang, Xue Ying Qiao, Hua Wang, Gao Feng Li, Yuan Zhu, Jian Zhong Cao, Jun Xin Wu, Tao Wu, Su Yu ZhuMei Shi, Li Ming Xu, Zhi Yong Yuan, Hang Su, Yu Qin Song, Jun Zhu, Chen Hu, Ye Xiong Li

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences